000 | 02000 a2200589 4500 | ||
---|---|---|---|
005 | 20250517040655.0 | ||
264 | 0 | _c20161114 | |
008 | 201611s 0 0 eng d | ||
022 | _a1873-7560 | ||
024 | 7 |
_a10.1016/j.eururo.2015.06.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBudäus, Lars | |
245 | 0 | 0 |
_aInitial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy. _h[electronic resource] |
260 |
_bEuropean urology _cMar 2016 |
||
300 |
_a393-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aEdetic Acid _xadministration & dosage |
650 | 0 | 4 | _aGallium Isotopes |
650 | 0 | 4 | _aGallium Radioisotopes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKallikreins _xmetabolism |
650 | 0 | 4 | _aLymph Node Excision |
650 | 0 | 4 |
_aLymph Nodes _xdiagnostic imaging |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultimodal Imaging _xmethods |
650 | 0 | 4 |
_aOligopeptides _xadministration & dosage |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aPreoperative Care _xmethods |
650 | 0 | 4 |
_aProstate-Specific Antigen _xmetabolism |
650 | 0 | 4 | _aProstatectomy |
650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnostic imaging |
650 | 0 | 4 |
_aRadiopharmaceuticals _xadministration & dosage |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLeyh-Bannurah, Sami-Ramzi | |
700 | 1 | _aSalomon, Georg | |
700 | 1 | _aMichl, Uwe | |
700 | 1 | _aHeinzer, Hans | |
700 | 1 | _aHuland, Hartwig | |
700 | 1 | _aGraefen, Markus | |
700 | 1 | _aSteuber, Thomas | |
700 | 1 | _aRosenbaum, Clemens | |
773 | 0 |
_tEuropean urology _gvol. 69 _gno. 3 _gp. 393-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2015.06.010 _zAvailable from publisher's website |
999 |
_c25022499 _d25022499 |